• LABline
  • Magazine Archive
  • Webinars
  • Whitepapers
  • eBooks
  • Videos
  • Subscribe
    • ID 248170682 © Planetfelicity | Dreamstime.com
    dreamstime_xxl_248170682
    Infectious Disease

    WHO adds LC16m8 mpox vaccine to Emergency Use Listing

    LABline
    Nov. 21, 2024
    This decision is expected to facilitate increased and timely access to vaccines in communities where mpox outbreaks are surging.
    ID 7253322 © Suljo | Dreamstime.com
    dreamstime_xxl_7253322
    ID 322970657 © Leo Rohmann | Dreamstime.com
    dreamstime_xxl_322970657
    ID 263480337 © Viniciussouza06 | Dreamstime.com
    dreamstime_xxl_263480337
    ID 345720359 © Prostockstudio | Dreamstime.com
    dreamstime_xxl_345720359
    ID 330744468 © Wutianzeri | Dreamstime.com
    dreamstime_xxl_330744468
    ID 277310761 © Jlmcanally | Dreamstime.com
    dreamstime_xxl_277310761
    ID 202506718 © Dzmitry Skazau | Dreamstime.com
    dreamstime_xxl_202506718
    Infectious Disease

    Measles cases surge worldwide

    LABline
    Nov. 15, 2024
    Measles infected 10.3 million people in 2023.
    ID 340556497 © Svitlana Kuchina | Dreamstime.com
    dreamstime_xxl_340556497
    Cancer

    Drug combination prompts immune response in some resistant pancreatic cancers

    LABline
    Nov. 15, 2024
    New drug strategy studied by Johns Hopkins researchers.
    ID 7383872 © Cammeraydave | Dreamstime.com
    dreamstime_xxl_7383872
    Disease

    FDA approves gene therapy for treatment of AADC deficiency

    LABline
    Nov. 15, 2024
    The FDA granted approval of Kebilidi to PTC Therapeutics, Inc.
    ID 335783453 © Igor_Tichonow | Dreamstime.com
    dreamstime_xxl_335783453
    Diabetes

    Global diabetes cases increase four-fold over past decades

    LABline
    Nov. 14, 2024
    New data highlights urgent action needed.
    ID 76886763 © Jiri Hera | Dreamstime.com
    dreamstime_xxl_76886763
    Cancer

    Vaccine shows promise against aggressive breast cancer

    LABline
    Nov. 14, 2024
    Clinical trial targeted recurrence of hard-to-treat triple-negative breast cancer.
    Courtesy of the CDC
    18167
    Disease

    Certain HAIs decreased in 2023, according to the CDC

    LABline
    Nov. 13, 2024
    2023 National and State Healthcare-Associated Infections Progress Report.
    Courtesy of the CDC
    Sexually Transmitted Infections - United States 2024-2023.
    STIs/STDs

    STI epidemic may be slowing

    LABline
    Nov. 13, 2024
    CDC data shows that despite over 2 million sexually transmitted infections reported in 2023, the STI epidemic may be slowing.
    ID 329351828 © Starast | Dreamstime.com
    dreamstime_xxl_329351828
    Disease

    New discovery may lead to more effective treatment for cardiovascular disease

    LABline
    Nov. 13, 2024
    Case Western Reserve-led study identifies molecule that simulates inflammation-reducing effects of a low-fat diet.
    ID 343308523 © Yuri Arcurs | Dreamstime.com
    dreamstime_xxl_343308523
    Cancer

    Combination approach shows promise for treating rare, aggressive cancers

    LABline
    Nov. 13, 2024
    UCLA research finds that combining immunotherapy with chemotherapy is safe and effective for people with advanced small cell cancers in the bladder and prostate.

    Disease

    ID 146642679 © Monthira Yodtiwong | Dreamstime.com
    dreamstime_xxl_146642679
    ID 319235421 © Yuri Arcurs | Dreamstime.com
    dreamstime_xxl_319235421
    ID 51651973 © Wavebreakmedia Ltd | Dreamstime.com
    dreamstime_xxl_51651973
    ID 320261498 © Justlight | Dreamstime.com
    dreamstime_xxl_320261498
    ID 198961638 © Valiantsin Suprunovich | Dreamstime.com
    dreamstime_xxl_198961638
    ID 186156891 © Noipornpan | Dreamstime.com
    dreamstime_xxl_186156891
    ID 181843439 © Akesin | Dreamstime.com
    dreamstime_xxl_181843439